Publishing research using ab216471? Please let us know so that we can cite the reference in this datasheet.

ab216471 has been referenced in 1 publication.

  • Carretta M  et al. BRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9+ leukemic cells. PLoS One 12:e0189102 (2017). PubMed: 29240787

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

Sign up